Nordstrom Inc. (JWN) Falls 7.26% for February 19

Equities Staff |

One of the S&P 500’s big losers for Friday February 19 was Nordstrom Inc. (JWN). The company’s stock fell 7.26% to $48.89 on volume of 16.51 million shares.

The stock opened the day at 47.85 and traded between a low of $46.65 and a high of $49.75. The stock finished the day down $3.8262 per share. Nordstrom Inc. has an average daily volume of 3.68 million and a total float of 183.87 million shares. The 50-day SMA for Nordstrom Inc. is $50.08 and its 200-day SMA is $65.71. The high for the stock over the last 52 weeks is $83.16 and the low is $44.49.

Nordstrom Inc operates as a fashion specialty retailer, with 290 U.S. stores located in 38 states as well as a robust e-commerce business through Nordstrom.com and HauteLook. It has two reportable segments: Retail and Credit.

Nordstrom Inc. is centered in Seattle, WA, and has 73,500 employees. Today’s trading day leaves the company with a market cap of $8.99 billionwith a P/E Ratio of 15.1. The company has a P/S ratio of 0.95, P/B ratio of 6.38, and a -42.5.

For a complete fundamental analysis analysis of Nordstrom Inc., check out Equities.com’s Stock Valuation Analysis report for JWN. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…